The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Blennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789
Self-citationImproved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724
Self-citationTau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 716
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
Motter, R., Vigo‐Pelfrey, C., Kholodenko, D., Barbour, R., Johnson‐Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380413 · Cited by 701
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
(1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 666
Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.673 · Cited by 660
Self-citationTierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., & Nieuwstraten, P. (1988) · Neurology · doi:10.1212/wnl.38.3.359 · Cited by 613
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.373 · Cited by 573
Self-citationVandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., Van de Voorde, A., Martin, J., & Cras, P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09823.x · Cited by 495
Self-citationVanmechelen, E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van Der Perre, B., Sjögren, M., Andreasen, N., & Blennow, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01036-3 · Cited by 488
Self-citationIda, N., Hartmann, T., Pantel, J., Schrüder, J., Zerfass, R., Fürstl, H., Sandbrink, R., Masters, C. L., & Beyreuther, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22908 · Cited by 478
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
Hesse, C., Rosengren, L., Andreasen, N., Davidsson, P., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01697-9 · Cited by 450
Self-citationGalasko, D., Chang, L., Motter, R., Clark, C. M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.937 · Cited by 442
Clinical-Neuropathological Correlations in Alzheimer's Disease and Related Dementias
Galasko, D., Hansen, L. A., Katzman, R., Wiederholt, W., Masliah, E., Terry, R., Hill, L. R., Lessin, P., & Thal, L. J. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210060013 · Cited by 409
Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R., Simms, G., Beyreuther, K., & Masters, C. L. (1988) · Neurology · doi:10.1212/wnl.38.11.1688 · Cited by 369
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Tumani, H., Zerr, I., Lantsch, M., Kornhuber, J., Weber, T., Kretzschmar, H. A., & Poser, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00215-2 · Cited by 341
Kanai, M., Matsubara, E., Isoe, K., Urakami, K., Nakashima, K., Arai, H., Sasaki, H., Abe, K., Iwatsubo, T., Kosaka, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440108 · Cited by 340
Buerger, K., Zinkowski, R., Teipel, S. J., Tapiola, T., Arai, H., Blennow, K., Andreasen, N., Hofmann-Kiefer, K., DeBernardis, J., Kerkman, D., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.8.1267 · Cited by 277
Self-citationBoth total and phosphorylated tau are increased in Alzheimer's disease
Sjogren, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.5.624 · Cited by 253
Andreasen, N., Minthon, L., Vanmechelen, E., Vanderstichele, H., Davidsson, P., Winblad, B., & Blennow, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00617-5 · Cited by 239
Self-citationSjögren, M., Minthon, L., Davidsson, P., Granérus, A. K., Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070079 · Cited by 239
Self-citationAndreasen, N., Vanmechelen, E., Van de Voorde, A., Davidsson, P., Hesse, C., Tarvonen, S., Raiha, I., Sourander, L., Winblad, B., & Blennow, K. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.298 · Cited by 227
Self-citationVigo-Pelfrey, C., Seubert, P. P., Barbour, R., Blomquist, C., Lee, M., Lee, D., Coria, F., Chang, L., Miller, B., Lieberburg, I., et al. (1995) · Neurology · doi:10.1212/wnl.45.4.788 · Cited by 225
Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke
Hesse, C., Rosengren, L., Vanmechelen, E., Vanderstichele, H., Jensen, C., Davidsson, P., & Blennow, K. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-23-402 · Cited by 216
Self-citationJensen, M., Schr�der, J., Blomberg, M., Engvall, B., Pantel, J., Ida, N., Basun, H., Wahlund, L.-O., Werle, E., Jauss, M., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9 · Cited by 214
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
Andreasen, N., Minthon, L., Clarberg, A., Davidsson, P., Gottfries, J., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1488 · Cited by 212
Self-citationGlucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies
Higuchi, M., Tashiro, M., Arai, H., Okamura, N., Hara, S., Higuchi, S., Itoh, M., Shin, R.-W., Trojanowski, J. Q., & Sasaki, H. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7342 · Cited by 206
Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
Ishiguro, K., Ohno, H., Arai, H., Yamaguchi, H., Urakami, K., Park, J.-M., Sato, K., Kohno, H., & Imahori, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00476-0 · Cited by 175
Kohnken, R., Buerger, K., Zinkowski, R., Miller, C., Kerkman, D., DeBernardis, J., Shen, J., Möller, H.-J., Davies, P., & Hampel, H. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01178-2 · Cited by 173
Self-citationDecreased β-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Otto, M., Esselmann, H., Schulz-Schaeffer, W., Neumann, M., Schröter, A., Ratzka, P., Cepek, L., Zerr, I., Steinacker, P., Windl, O., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1099 · Cited by 171
Green, A. J. E., Harvey, R. J., Thompson, E. J., & Rossor, M. N. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00904-5 · Cited by 166
Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
Arai, H., Morikawa, Y.-I., Higuchi, M., Matsui, T., Clark, C. M., Miura, M., Machida, N., Lee, V. M.-Y., Trojanowski, J. Q., & Sasaki, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6908 · Cited by 159
Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies
Kanemaru, K., Kameda, N., & Yamanouchi, H. (2000) · Neurology · doi:10.1212/wnl.54.9.1875 · Cited by 155
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
Galasko, D. R., Clark, C., Chang, L., Miller, B. L., Green, R. C., Motter, R. N., & Seubert, P. A. (1997) · Neurology · doi:10.1212/wnl.48.3.632 · Cited by 151
Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
Tamaoka, A., Sawamura, N., Fukushima, T., Shoji, S., Matsubara, E., Shoji, M., Hirai, S., Furiya, Y., Endoh, R., & Mori, H. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00314-0 · Cited by 144
Update on the dementia spectrum of depression
Emery, V. O., & Oxman, T. E. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.3.305 · Cited by 137
Increased cerebrospinal fluid tau in patients with Alzheimer's disease
Jensen, M., Basun, H., & Lannfelt, L. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11297-a · Cited by 131
Low frequency of post-lumbar puncture headache in demented patients
Blennow, K., Wallin, A., & Häger, O. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04221.x · Cited by 129
Self-citationMori, H., Hosoda, K., Matsubara, E., Nakamoto, T., Furiya, Y., Endoh, R., Usami, M., Shoji, M., Maruyama, S., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11291-4 · Cited by 128
CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study
Arai, H., Ishiguro, K., Ohno, H., Moriyama, M., Itoh, N., Okamura, N., Matsui, T., Morikawa, Y.-I., Horikawa, E., Kohno, H., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7501 · Cited by 123
Diagnostic accuracy of alzheimer’s disease: A neuropathological study
Kosunen, O., Soininen, H. S., Paljärvi, L., Heinonen, O., Talasniemi, S., & Riekkinen, P. J. (1996) · Acta Neuropathologica · doi:10.1007/s004010050412 · Cited by 122
Hampel, H. J., Büerger, K., Kohnken, R. E., Teipel, S. J., Zinkowski, R. P., Moeller, H., Rapoport, S. I., & Davies, P. (2001) · Annals of Neurology · doi:10.1002/ana.111 · Cited by 102
Self-citationCombined assessment of tau and neuronal thread protein in Alzheimer’s disease CSF
Kahle, P. J., Jakowec, M. W., Teipel, S. J., Hampel, H. J., Petzinger, G. M., Monte, D. A. D., Silverberg, G. D., Möller, H. ‐., Yesavage, J. A., Tinklenberg, J. R., et al. (2000) · Neurology · doi:10.1212/wnl.54.7.1498 · Cited by 94
Self-citationHampel, H. J., Teipel, S. J., Padberg, F., Haslinger, A., Riemenschneider, M., Schwarz, M., Kötter, H. U., Scheloske, M., Buch, K., Stübner, S., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01146-4 · Cited by 93
Self-citationCerebrospinal protein tau is elevated in early Alzheimer's disease
Riemenschneider, M. J., Buch, K., Schmolke, M., Kurz, A., & Guder, W. G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12810-x · Cited by 90
Combined assessment of tau and neuronal thread protein in Alzheimer’s disease CSF
Averback, P. (2000) · Neurology · doi:10.1212/wnl.55.7.1068 · Cited by 89
Kurz, A., Riemenschneider, M., Buch, K., Willoch, F., Bartenstein, P., Müller, U., & Guder, W. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199812000-00020 · Cited by 85
Riemenschneider, M. J., Schmolke, M., Lautenschlager, N. T., Guder, W. G., Vanderstichele, H., Vanmechelen, E., & Kurz, A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00976-9 · Cited by 84
Self-citationTau Protein in Cerebrospinal Fluid
Mecocci, P., Cherubini, A., Bregnocchi, M., Chionne, F., Cecchetti, R., Lowenthal, D. T., & Senin, U. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00015 · Cited by 81
Skoog, I. G., Vanmechelen, E., Andreasson, L., Palmertz, B., Davidsson, P., Hesse, C., & Blennow, K. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0052 · Cited by 77
Self-citationTau protein is a potential biological marker for normal pressure hydrocephalus
Kudo, T., Mima, T., Hashimoto, R., Nakao, K., Morihara, T., Tanimukai, H., Tsujio, I., Koike, Y., Tagami, S., Mori, H., et al. (2000) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2000.00658.x · Cited by 76
Sjögren, M. J. C., Gisslén, M., Vanmechelen, E., & Blennow, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02285-6 · Cited by 73
Self-citationDevelopment of a Specific Diagnostic Test for Measurement of β-Amyloid (1-42) [βA4(l-42)] in CSF
Vanderstichele, H., Blennow, K., D'Heuvaert, N., Buyse, M.-A., Wallin, A., Andreasen, N. C., Seubert, P. A., VOORDE, A. V. D., & Vanmechelen, E. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_110 · Cited by 70
Self-citationBuch, K., Padberg, F., Nolde, T., Teipel, S. J., Stübner, S., Haslinger, A., Schwarz, M., Sunderland, T., Arai, H., Rapoport, S. I., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00845-9 · Cited by 65
Self-citationDiagnostic accuracy of Alzheimer’s disease: A clinicopathological study
Jellinger, K. A. (1996) · Acta Neuropathologica · doi:10.1007/s004010050418 · Cited by 64
CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
Tapiola, T., Lehtovirta, M., Ramberg, J., Helisalmi, S., Linnaranta, K., Riekkinen, P., & Soininen, H. S. (1998) · Neurology · doi:10.1212/wnl.50.1.169 · Cited by 63
Urakami, K., Mori, M., Wada, K., Kowa, H., Takeshima, T., Arai, H., Sasaki, H., Kanai, M., Shoji, M., Ikemoto, K., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00923-9 · Cited by 58
Severity of family distress of schizophrenia—fact or artifact?
Damodaran, S. S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03443.x · Cited by 57
Nishimura, T., Takeda, M., NAKAMURA, Y., & al., E. (1998) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.1998.20.3.485673 · Cited by 56
Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease.
Munroe, W. A., Southwick, P. C., Chang, L. J., Scharre, D. W., Echols, C. L., Fu, P. C., Whaley, J. M., & Wolfert, R. (1995) · PubMed · Cited by 55
No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia
Arai, H., Satoh‐Nakagawa, T., Higuchi, M., Morikawa, Y.-I., Miura, M., Kawakami, H., Seki, H., Takase, S., & Sasaki, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00781-2 · Cited by 51
Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.
Morikawa, Y., Arai, H., Matsushita, S., Kato, M., Higuchi, S., Miura, M., Kawakami, H., Higuchi, M., Okamura, N., Tashiro, M., et al. (1999) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04156.x · Cited by 49
Molina, L., Touchon, J., Herpé, M., Lefranc, D., Duplan, L., Cristol, J., Sabatier, R., Vermersch, P., Pau, B., & Mourton-Gilles, C. (1999) · Neuroreport · doi:10.1097/00001756-199911260-00005 · Cited by 49
Decreased Levels of Amyloid-β 1-42 in Cerebrospinal Fluid of Creutzfeldt–Jakob Disease Patients
Everbroeck, B. V., Green, A. J. E., Pals, P., Martin, J. J., & Cras, P. P. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1606 · Cited by 47
Increased CSF tau protein in corticobasal degeneration
Mitani, K., Furiya, Y., Uchihara, T., Ishii, K., Yamanouchi, H., Mizusawa, H., & Mori, H. (1997) · Journal of Neurology · doi:10.1007/s004150050173 · Cited by 47
Arai, H., Higuchi, S., & Sasaki, H. (2009) · Gerontology · doi:10.1159/000213879 · Cited by 42
Rösler, N., Wichart, I., & Jellinger, K. A. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.237-a · Cited by 37
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology.
Ashton, N. J., Pascoal, T. A., Karikari, T. K., Benedet, A. L., Lantero-Rodriguez, J., Brinkmalm, G., Snellman, A., Schöll, M., Troakes, C., Hye, A., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02275-6 · Cited by 719
Self-citationSunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
[ 18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Xia, C., Arteaga, J., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., Mocharla, V. P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.008 · Cited by 605
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
Blennow, K. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.213 · Cited by 477
Self-citation
Metadata
- Authors
- Blennow, K., Vanmechelen, E., & Hampel, H.
- Venue
- Molecular Neurobiology
- Published
- 2001
- Volume
- 24
- Issue
- 1-3
- Pages
- 087-098
- ISSN
- 0893-7648 (ISSN-L)
- OpenAlex
- W2077303669
- Cited by
- 267
- References
- 77
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.